DuChemBIO Co.,Ltd. (KOSDAQ:176750)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,670.00
-80.00 (-1.19%)
At close: Aug 11, 2026

DuChemBIO Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Revenue
39,81838,57235,60134,695
Revenue Growth
11.67%8.35%2.61%-
Gross Profit
15,11214,23012,23411,797
Operating Income
8,0307,4435,0765,256
Net Income
6,9756,4807,9944,001
Earnings Per Share
246.97228.00297.54149.54
EPS Growth
-10.93%-23.37%98.97%-

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
South Korea
38,46035,55534,592
North America
18.025.3759.79
Oceania
58.8322.0513.28
Asia
35.6818.0930.72
Total
38,57235,60134,695

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Cash & Investments
16,81515,45010,6901,981
Total Debt
22,33124,45917,55121,755
Net Cash (Debt)
-5,516-9,009-6,861-19,775
Net Cash Growth
----
Net Cash Per Share
-195.37-317.09-255.39-739.20

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
11,5389,9397,0298,441
Capital Expenditures
-838.88-865.67-1,589-1,147
Free Cash Flow
10,6999,0745,4407,293
Free Cash Flow Growth
106.79%66.81%-25.41%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Gross Margin
37.95%36.89%34.36%34.00%
Operating Margin
20.17%19.30%14.26%15.15%
Pretax Margin
18.39%17.26%15.63%11.68%
Profit Margin
17.52%16.80%22.45%11.53%
FCF Margin
26.87%23.52%15.28%21.02%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PE Ratio
26.6441.6429.0137.10
Forward PE
-15.80--
P/FCF Ratio
17.4329.7442.6320.35
PS Ratio
4.687.006.514.28